Trial Outcomes & Findings for Omega Tots Long Term Follow-up (NCT NCT05191823)
NCT ID: NCT05191823
Last Updated: 2026-08-11
Results Overview
Differential Ability Scales-II General Conceptual Ability assessment is a measure of general cognitive ability and is used to assess and identify children's cognitive strengths and weaknesses. The general cognitive ability score has a range from 30 to 170 (mean=100; SD=15). A low score indicates poor performance, and a high score indicates best performance.
ACTIVE_NOT_RECRUITING
NA
377 participants
A single study visit when the child is between 8.5 years to 10.5 years
2026-08-11
Participant Flow
Participant milestones
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
Overall Study
STARTED
|
189
|
188
|
|
Overall Study
COMPLETED
|
158
|
152
|
|
Overall Study
NOT COMPLETED
|
31
|
36
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Omega Tots Long Term Follow-up
Baseline characteristics by cohort
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=189 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=188 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
Total
n=377 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
9.2 years
n=54 Participants
|
9.3 years
n=54 Participants
|
9.2 years
n=27 Participants
|
|
Sex: Female, Male
Female
|
84 Participants
n=54 Participants
|
98 Participants
n=54 Participants
|
182 Participants
n=27 Participants
|
|
Sex: Female, Male
Male
|
105 Participants
n=54 Participants
|
90 Participants
n=54 Participants
|
195 Participants
n=27 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=54 Participants
|
0 Participants
n=54 Participants
|
0 Participants
n=27 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=54 Participants
|
1 Participants
n=54 Participants
|
3 Participants
n=27 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=54 Participants
|
0 Participants
n=54 Participants
|
0 Participants
n=27 Participants
|
|
Race (NIH/OMB)
Black or African American
|
52 Participants
n=54 Participants
|
53 Participants
n=54 Participants
|
105 Participants
n=27 Participants
|
|
Race (NIH/OMB)
White
|
114 Participants
n=54 Participants
|
122 Participants
n=54 Participants
|
236 Participants
n=27 Participants
|
|
Race (NIH/OMB)
More than one race
|
21 Participants
n=54 Participants
|
12 Participants
n=54 Participants
|
33 Participants
n=27 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=54 Participants
|
0 Participants
n=54 Participants
|
0 Participants
n=27 Participants
|
|
Region of Enrollment
United States
|
189 participants
n=54 Participants
|
188 participants
n=54 Participants
|
377 participants
n=27 Participants
|
PRIMARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsDifferential Ability Scales-II General Conceptual Ability assessment is a measure of general cognitive ability and is used to assess and identify children's cognitive strengths and weaknesses. The general cognitive ability score has a range from 30 to 170 (mean=100; SD=15). A low score indicates poor performance, and a high score indicates best performance.
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=156 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=151 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
General Cognitive Ability Score(Differential Ability Scales, Second Edition-DAS-II)
|
94.3 score on a scale
Standard Deviation 14.8
|
96.9 score on a scale
Standard Deviation 16.6
|
PRIMARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsClinical evaluation of Language Fundamentals, 5th edition core tests is a comprehensive measure of language and can assess children's written and oral language skills, as well as their reading comprehension. The core language score has a range from 30 to 170 (mean=100; SD=15). A low score indicates poor performance, and a high score indicates best performance.
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=156 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=152 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
Core Language Score (Clinical Evaluation of Language Fundamentals, Fifth Edition-CELF-5)
|
93.2 score on a scale
Standard Deviation 14.8
|
92.8 score on a scale
Standard Deviation 17.1
|
PRIMARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsPopulation: Some participants did not take part in this protocol component.
The NIH Toolbox Cognition Battery is a multi-dimensional set of brief measures assessing cognitive function. The Flanker, Dimensional Card Sort, and Pattern Comparison subtests measure executive function, processing speed, and attention. Standard scores have a range from 30 to 170 (mean=100; SD=15). A low score indicates poor performance, and a high score indicates best performance..
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=152 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=148 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
Executive Function (NIH Toolbox)
|
92.4 standard score
Standard Deviation 12.3
|
91.2 standard score
Standard Deviation 12.3
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe Grooved Pegboard task measures eye-hand coordination and motor speed by requiring children to insert pegs into a board. The score is the time to place the pegs. If the child reaches the time limit of 3 minutes, then the score is the number of pegs placed. A faster time and lower number of pegs dropped is indicative of better performance.
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=158 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=152 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
Grooved Pegboard Task
|
104.8 seconds
Standard Deviation 31.2
|
102 seconds
Standard Deviation 29.1
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe Weschler Intelligence Scales for Children-V Digit Span and Picture Span subtests assess working memory. The working memory index composite score has a range from 30-170 (mean=100; SD=15). A low score indicates poor performance, and a high score indicates best performance.
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=154 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=149 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
Select Subtest From the Wechsler Intelligence Scales for Children, Fifth Edition (WISC-V)
|
94.6 score on a scale
Standard Deviation 15
|
93.6 score on a scale
Standard Deviation 16.1
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe Kaufman Test of Educational Achievement-3 is an assessment of key academic skills. The Letter and Word Recognition, Math Computation, Object Naming Facility, and Associative Fluency Subtests measure children's reading, math, and written language skills. The standard score has a range from 30-170 (mean=100; SD=15). A low score indicates poor performance, and a high score indicates best performance.
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=155 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=151 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
Select Subtests From the Kaufman Test of Educational Achievement, Third Edition (KTEA-3)
|
91.5 score on a scale
Standard Deviation 18.1
|
94.3 score on a scale
Standard Deviation 16.8
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsTo assess children's body composition, height (in centimeters) is measured. This is converted to a z score for age and sex based on Child Growth Standards from the World Health Organization. The z score indicates the number of standard deviations away from the mean. A z score of 0 is equal to the mean of a reference population (children the same age and sex). Values less than 0 indicate values lower than the reference population, while values greater than 0 indicate values higher than the reference population.
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=155 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=145 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
Anthropometrics-Body Composition (Height)
|
.23 z-score
Standard Deviation 1.03
|
.29 z-score
Standard Deviation 1.01
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsTo assess children's body composition, weight (in kilograms) is measured. This is converted to a z score for age and sex based on Child Growth Standards from the World Health Organization. The z score indicates the number of standard deviations away from the mean. A z score of 0 is equal to the mean of a reference population (children the same age and sex). Values less than 0 indicate values lower than the reference population, while values greater than 0 indicate values higher than the reference population.
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=155 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=147 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
Anthropometrics-Body Composition (Weight)
|
.66 z-score
Standard Deviation 1.22
|
.66 z-score
Standard Deviation 1.21
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsTo assess children's adiposity, a bioelectric impedance is used to measure body fat percent. Child's height and weight will be combined to report BMI (kg/m\^2). These measurements are converted to a z score for age and sex based on Child Growth Standards from the World Health Organization. The z score indicates the number of standard deviations away from the mean. A z score of 0 is equal to the mean of a reference population (children the same age and sex). Values less than 0 indicate values lower than the reference population, while values greater than 0 indicate values higher than the reference population.
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=155 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=145 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
Anthropometrics-Adiposity
|
.73 z-score
Standard Deviation 1.28
|
.69 z-score
Standard Deviation 1.19
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe Behavior Rating Inventory of Executive Function, 2nd ed., is completed by the child's caregiver and teacher to measure a range of executive functioning capabilities in children. The BRIEF-2 yields nine clinical scales that measure various aspects of executive function plus three broad indices: behavioral regulation, emotion regulation, and cognitive regulation. Scores are summed to obtain a Global Executive Composite Score that will be expressed as a t score (range= \[35-90\]; (mean=50; SD=10), where a higher score indicates greater dysregulation .
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=160 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=155 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
Behavior Rating Inventory of Executive Function, 2nd Edition (BRIEF-2)
|
55.4 t-score
Standard Deviation 11.3
|
56.9 t-score
Standard Deviation 11.7
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe Teacher Report Form (syndrome and DSM-Oriented subscales) is completed by the child's teacher to reflect on the child's behavior in the previous six months. Scores are summed to provide a total problems score. Scores are also computed to measure the following subscales: internalizing problems, externalizing problems, anxious/depressed, withdrawn/depressed, somatic complaints, social problems, thought problems, attention problems, rule-breaking behavior, aggression behavior, affective problems, anxiety problems, somatic problems, attention deficit/hyperactivity problems, oppositional defiant problems, conduct problems. Scores will be expressed as a t-score (range= \[33-100\]; mean=50; SD=10), where a lower score indicates a more optimal outcome.
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=132 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=137 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
Select Subscales From the Teacher Report Form 6-18
|
51.1 score on a scale
Standard Deviation 8.8
|
52.6 score on a scale
Standard Deviation 9.2
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe Child Behavior Checklist is completed by the child' caregiver to reflect their child's behavior in the previous six months. Scores were summed to provide total competence score. Total competence scores will be expressed as a t-score (range= \[20-100\]; mean=50; SD=10), where a higher score reflects a more optimal outcome.
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=159 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=156 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
Child Behavior Checklist 6-18 (CBCL) - Competence
|
39.6 t-score
Standard Deviation 10.1
|
40.7 t-score
Standard Deviation 10.0
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe National Survey of Children's Health module captures child developmental and behavioral diagnoses and other major diagnoses via parent report . A binary variable will be formed to indicate if a child has been diagnosed with each condition or not (yes, no).
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=161 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=156 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
National Survey of Children's Health Module - Learning Disability
|
33 Participants
|
33 Participants
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe Emotion Regulation Checklist is completed by the child's caregiver to measure child's ability to manage their emotions. Scores are grouped and summed to yield Emotion Regulation scale (range=10-40). Higher scores on the Emotion Regulation scale indicates more ability to regulate
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=156 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=161 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
Emotion Regulation Checklist - Emotion Regulation
|
26.3 score on a scale
Standard Deviation 3.9
|
25.9 score on a scale
Standard Deviation 3.7
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe NIH Toolbox Friendship (Ages 8-17) Fixed Form is a 5-item questionnaire that measures peer relationships and assesses the quality of relationships with friends and other acquaintances over the past month. Scores will be expressed as a t-score (range= \[16-68\]; mean=50; SD=10), where a higher score indicates stronger peer relationships.
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=157 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=152 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
NIH Toolbox Friendship Fixed Form
|
44.4 t-score
Standard Deviation 10.3
|
44.9 t-score
Standard Deviation 9.5
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe NIH Toolbox Positive Peer Interaction Form (Ages 3-12) is a 4-item questionnaire that measures child peer relationships via parent report. Scores will be expressed as a t-score (range= \[-8-63\] ; mean=50; SD=10), where a higher score indicates stronger peer relationships.
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=157 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=152 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
NIH Toolbox Positive Peer Interaction Parent Report Fixed Form
|
46.7 t-score
Standard Deviation 10.6
|
47.5 t-score
Standard Deviation 11.4
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe Child Sleep Habits Questionnaire-abbreviated measures child sleep pattern and behaviors via parent report. Parents are asked to report on the child's bedtime behavior, sleep duration, and behavior during sleep. Scores are summed to give the total sleep disturbance score (range 33-99). Scores are also grouped and summed to yield eight subscales that measure different aspects of sleep. A higher score is indicative of more sleep problems .
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=161 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=156 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
Child Sleep Habits Questionnaire-abbreviated Measure
|
38.2 score on a scale
Standard Deviation 5.1
|
38.6 score on a scale
Standard Deviation 4.6
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe Child Behavior Checklist is completed by the child' caregiver to reflect their child's behavior in the previous six months. Scores were summed to provide problem scores. T Problem scores will be expressed as a t-score (range= \[25,100\]; mean=50; SD=10), where a lower score reflects a more optimal outcome.
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=161 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=156 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
Child Behavior Checklist 6-18 (CBCL) - Problems
|
51.7 t-score
Standard Deviation 12.0
|
52.6 t-score
Standard Deviation 11.4
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe National Survey of Children's Health module captures child developmental and behavioral diagnoses and other major diagnoses via parent report . A binary variable will be formed to indicate if a child has been diagnosed with each condition or not (yes, no).
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=161 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=156 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
National Survey of Children's Health Module - Developmental Delay
|
46 Participants
|
43 Participants
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe National Survey of Children's Health module captures child developmental and behavioral diagnoses and other major diagnoses via parent report . A binary variable will be formed to indicate if a child has been diagnosed with each condition or not (yes, no).
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=161 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=156 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
National Survey of Children's Health Module - INtellectual Disability
|
2 Participants
|
6 Participants
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe National Survey of Children's Health module captures child developmental and behavioral diagnoses and other major diagnoses via parent report . A binary variable will be formed to indicate if a child has been diagnosed with each condition or not (yes, no).
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=161 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=156 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
National Survey of Children's Health Module - Speech or Other Language Disorder
|
43 Participants
|
32 Participants
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe National Survey of Children's Health module captures child developmental and behavioral diagnoses and other major diagnoses via parent report . A binary variable will be formed to indicate if a child has been diagnosed with each condition or not (yes, no).
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=161 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=156 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
National Survey of Children's Health Module - Behavioral or Conduct Problems
|
29 Participants
|
30 Participants
|
SECONDARY outcome
Timeframe: A single study visit when the child is between 8.5 years to 10.5 yearsThe Emotion Regulation Checklist is completed by the child's caregiver to measure child's ability to manage their emotions. Scores are grouped and summed to yield a Lability/Negativity (range=14-56) scale. Higher scores on the Lability/Negativity scale reflect greater dysregulation .
Outcome measures
| Measure |
Docosahexaenoic Acid + Arachidonic Acid
n=161 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
|
Placebo
n=156 Participants
Corn oil supplement
Placebo: 400 mg corn oil per day for 6 months
|
|---|---|---|
|
Emotion Regulation Checklist - Lability/Negativity
|
26.0 score on a scale
Standard Deviation 6.7
|
26.4 score on a scale
Standard Deviation 6.6
|
Adverse Events
Adverse Events Were Not Assessed During This Follow-up Study
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Sarah Keim, Principal Investigator
Nationwide Children's Hospital
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place